In addition, the M-MDSC signature was also enriched in LS AML with KMT2A::AFF1 when compared with LC AML with KMT2A::AFF1, suggesting the possibility that its characteristics are derived from LS rather than from the AFF1 fusion (Fig. 2e). Here, KMT2A is linked to acute myeloid leukemia.